+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

Cutaneous Lupus Erythematosus (CLE) Patient Pool Analysis, Market Size and Market Forecast APAC - 2034 - Product Thumbnail Image

Cutaneous Lupus Erythematosus (CLE) Patient Pool Analysis, Market Size and Market Forecast APAC - 2034

  • Report
  • February 2024
  • 120 Pages
  • Asia Pacific
From
Antibody-Mediated Graft Rejection Patient Pool Analysis, Market Size and Market Forecast APAC - 2034 - Product Thumbnail Image

Antibody-Mediated Graft Rejection Patient Pool Analysis, Market Size and Market Forecast APAC - 2034

  • Report
  • February 2024
  • 120 Pages
  • Asia Pacific
From
US HUMIRA Market Size, Forecast, and Market Insight - 2032 - Product Thumbnail Image

US HUMIRA Market Size, Forecast, and Market Insight - 2032

  • Report
  • February 2024
  • 30 Pages
  • United States
United States Hereditary Angioedema Therapeutics Market, By Region, Competition, Forecast and & Opportunities, 2019-2029F - Product Thumbnail Image

United States Hereditary Angioedema Therapeutics Market, By Region, Competition, Forecast and & Opportunities, 2019-2029F

  • Report
  • April 2024
  • 82 Pages
  • United States
From
Allergic Rhinitis Patient Pool Analysis, Market Size and Market Forecast APAC - 2034 - Product Thumbnail Image

Allergic Rhinitis Patient Pool Analysis, Market Size and Market Forecast APAC - 2034

  • Report
  • February 2024
  • 120 Pages
  • Asia Pacific
From
Ulcerative Colitis Patient Pool Analysis, Market Size and Market Forecast APAC - 2034 - Product Thumbnail Image

Ulcerative Colitis Patient Pool Analysis, Market Size and Market Forecast APAC - 2034

  • Report
  • February 2024
  • 120 Pages
  • Asia Pacific
From
Rheumatoid Arthritis (RA) Patient Pool Analysis, Market Size and Market Forecast APAC - 2034 - Product Thumbnail Image

Rheumatoid Arthritis (RA) Patient Pool Analysis, Market Size and Market Forecast APAC - 2034

  • Report
  • February 2024
  • 120 Pages
  • Asia Pacific
From
Autoimmune Uveitis Patient Pool Analysis, Market Size and Market Forecast APAC - 2034 - Product Thumbnail Image

Autoimmune Uveitis Patient Pool Analysis, Market Size and Market Forecast APAC - 2034

  • Report
  • February 2024
  • 120 Pages
  • Asia Pacific
From
Lupus Nephritis Patient Pool Analysis, Market Size and Market Forecast APAC - 2034 - Product Thumbnail Image

Lupus Nephritis Patient Pool Analysis, Market Size and Market Forecast APAC - 2034

  • Report
  • February 2024
  • 120 Pages
  • Asia Pacific
From
Crohn's Disease Patient Pool Analysis, Market Size and Market Forecast APAC - 2034 - Product Thumbnail Image

Crohn's Disease Patient Pool Analysis, Market Size and Market Forecast APAC - 2034

  • Report
  • February 2024
  • 120 Pages
  • Asia Pacific
From
HIV Treatment Drugs Market in Africa 2024-2028 - Product Thumbnail Image

HIV Treatment Drugs Market in Africa 2024-2028

  • Report
  • July 2024
  • 162 Pages
  • Africa
From
United States Hereditary Angioedema Therapeutics Market Report and Forecast 2024-2032 - Product Thumbnail Image

United States Hereditary Angioedema Therapeutics Market Report and Forecast 2024-2032

  • Report
  • August 2024
  • 160 Pages
  • United States
From
Europe Androgenetic Alopecia Market Size, Share & Trends Analysis Report By Treatment (Pharmaceuticals, and Devices), By Gender (Male, and Female), By Sales Channel, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

Europe Androgenetic Alopecia Market Size, Share & Trends Analysis Report By Treatment (Pharmaceuticals, and Devices), By Gender (Male, and Female), By Sales Channel, By Country and Growth Forecast, 2023 - 2030

  • Report
  • March 2024
  • 127 Pages
  • Europe
From
Asia Pacific Androgenetic Alopecia Market Size, Share & Trends Analysis Report By Treatment (Pharmaceuticals, and Devices), By Gender (Male, and Female), By Sales Channel, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

Asia Pacific Androgenetic Alopecia Market Size, Share & Trends Analysis Report By Treatment (Pharmaceuticals, and Devices), By Gender (Male, and Female), By Sales Channel, By Country and Growth Forecast, 2023 - 2030

  • Report
  • March 2024
  • 128 Pages
  • Asia Pacific
From
North America Androgenetic Alopecia Market Size, Share & Trends Analysis Report By Treatment (Pharmaceuticals, and Devices), By Gender (Male, and Female), By Sales Channel, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

North America Androgenetic Alopecia Market Size, Share & Trends Analysis Report By Treatment (Pharmaceuticals, and Devices), By Gender (Male, and Female), By Sales Channel, By Country and Growth Forecast, 2023 - 2030

  • Report
  • March 2024
  • 119 Pages
  • North America
From
LAMEA Androgenetic Alopecia Market Size, Share & Trends Analysis Report By Treatment (Pharmaceuticals, and Devices), By Gender (Male, and Female), By Sales Channel, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

LAMEA Androgenetic Alopecia Market Size, Share & Trends Analysis Report By Treatment (Pharmaceuticals, and Devices), By Gender (Male, and Female), By Sales Channel, By Country and Growth Forecast, 2023 - 2030

  • Report
  • March 2024
  • 128 Pages
  • Africa, Middle East
From
North America Glucosamine Market Size, Share & Trends Analysis Report By Application, By Product (Glucosamine Sulfate, Glucosamine Hydrochloride, N-acetyl Glucosamine, and Others), By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

North America Glucosamine Market Size, Share & Trends Analysis Report By Application, By Product (Glucosamine Sulfate, Glucosamine Hydrochloride, N-acetyl Glucosamine, and Others), By Country and Growth Forecast, 2023 - 2030

  • Report
  • January 2024
  • North America
From
LAMEA Glucosamine Market Size, Share & Trends Analysis Report By Application, By Product (Glucosamine Sulfate, Glucosamine Hydrochloride, N-acetyl Glucosamine, and Others), By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

LAMEA Glucosamine Market Size, Share & Trends Analysis Report By Application, By Product (Glucosamine Sulfate, Glucosamine Hydrochloride, N-acetyl Glucosamine, and Others), By Country and Growth Forecast, 2023 - 2030

  • Report
  • January 2024
  • Middle East, Africa
From
Europe Glucosamine Market Size, Share & Trends Analysis Report By Application, By Product (Glucosamine Sulfate, Glucosamine Hydrochloride, N-acetyl Glucosamine, and Others), By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

Europe Glucosamine Market Size, Share & Trends Analysis Report By Application, By Product (Glucosamine Sulfate, Glucosamine Hydrochloride, N-acetyl Glucosamine, and Others), By Country and Growth Forecast, 2023 - 2030

  • Report
  • January 2024
  • Europe
From
Asia Pacific Glucosamine Market Size, Share & Trends Analysis Report By Application, By Product (Glucosamine Sulfate, Glucosamine Hydrochloride, N-acetyl Glucosamine, and Others), By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

Asia Pacific Glucosamine Market Size, Share & Trends Analysis Report By Application, By Product (Glucosamine Sulfate, Glucosamine Hydrochloride, N-acetyl Glucosamine, and Others), By Country and Growth Forecast, 2023 - 2030

  • Report
  • January 2024
  • Asia Pacific
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more